Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.
about
The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models.Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress.In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations.Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13).In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403.Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic
P2860
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Beta-arrestin 2 rather than G ...... /orphanin FQ receptor ligands.
@en
type
label
Beta-arrestin 2 rather than G ...... /orphanin FQ receptor ligands.
@en
prefLabel
Beta-arrestin 2 rather than G ...... /orphanin FQ receptor ligands.
@en
P2093
P2860
P50
P1433
P1476
Beta-arrestin 2 rather than G ...... /orphanin FQ receptor ligands.
@en
P2093
P2860
P304
P356
10.1016/J.NEUROPHARM.2016.02.003
P577
2016-02-08T00:00:00Z